👨‍⚕️ Medical Team

DOZA Physicians & Specialists

DOZA is a medical platform with a team of endocrinologists, nutritionists, and metabolic-health specialists who oversee every client protocol. This is the E-E-A-T foundation (experience, expertise, authoritativeness, trust) — the basis of our work with approved GLP-1, compounded analogs, and research programs.

Anastasia Shapoval — metabolic programs and weight control specialist DOZA

Anastasia Shapoval

Metabolic Programs and Weight Control Specialist

5 years of experience

Anastasia Shapoval — founder of DOZA, expert in metabolic programs and weight control.

  • Weight management programs
  • GLP-1 program support
  • Metabolic health
  • Nutritiology
👩‍⚕️

Olena Kovalchuk

Medical Reviewer, Endocrinologist

10+ years of clinical experience

Verifies accuracy of medical information on doza.clinic. Specializes in GLP-1 agonists and metabolic disorders.

  • GLP-1/GIP agonists (tirzepatide, semaglutide)
  • Metabolic syndrome and obesity
  • Peptide therapy
  • Medical content review
👩‍💻

Iryna Bondarenko

Content Specialist, Nutrition Science

6+ years in medical journalism

Writes and edits DOZA blog articles, translating complex clinical data into accessible content. Certified nutritionist.

  • Medical journalism
  • Nutrition science and dietetics
  • Evidence-based medical content
  • SEO for medical materials
Melnyk Natalia — gastroenterologist DOZA

Melnyk Natalia

Gastroenterologist

10 years of experience

GI tract diagnostics and correction during the program. Individual nutrition recommendations.

  • GI tract functional disorders
  • GLP-1 program adaptation
  • Nutritiology
Savchenko Dmytro — endocrinologist DOZA

Savchenko Dmytro

Endocrinologist

7 years of experience

Specializes in obesity and metabolic disorders. Individual weight correction program selection considering hormonal profile.

  • Obesity and metabolic syndrome
  • Hormonal diagnostics
  • Insulin resistance

How the team supports each product category

  • Approved (Ozempic, Mounjaro): full clinical support — initial consultation, dose titration, side-effect monitoring, scheduled review every 4 weeks.
  • Branded analog (Biopatid by Biopell Medical): the same support protocol plus transparent disclosure that this is a third-party manufactured product.
  • Investigational Phase 3 (Retatrutide, Cagrilintide): dedicated medical consultation with mandatory disclosure of "not yet registered" status, risk assessment, and monitoring.
  • Research-grade peptides: educational support, links to the scientific database, recommendations from nutritionist physicians.

🏛️ Research Policy

How DOZA distinguishes approved, compounded, investigational, and research-grade products

◐ About DOZA

Founding story, values, and support methodology